Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide Maintenance in Advanced Mantle Cell Lymphoma
NCT02354313Phase 3Unknown
- Sponsor
- Fondazione Italiana Linfomi
- Start
- May 2010
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of lenalidomide in mantle cell lymphoma (MCL), sponsored by Fondazione Italiana Linfomi. Status: unknown.
02
Drugs
lenalidomide
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT02354313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02354313.